covid -19驱动的免疫麻痹和细胞因子风暴:血液学家能参与这场战斗吗?

Marchetti M
{"title":"covid -19驱动的免疫麻痹和细胞因子风暴:血液学家能参与这场战斗吗?","authors":"Marchetti M","doi":"10.23880/hij-16000170","DOIUrl":null,"url":null,"abstract":"COVID-19 pandemia is a major health emergency causing hundreds of deaths worldwide. The high reported morbidity has been related to derangement of the immune system, cytokine overproduction and endothelial dysfunction. Several drugs currently marketed for blood disorders are being tested for potential clinical benefit in patients with COVID-19 and hematologists are valuable partners for multidisciplinary research projects assessing host-targeted therapies. This review attempts to highlight the pathogenesis of lymphopenia in COVID-19 disease and the possible treatment pathways. While discussing the pattern of cytokine hyperproduction, we also focused on anti-cytokine drugs being tested for COVID-19 disease but currently prescribed for blood disorders.","PeriodicalId":245976,"journal":{"name":"Haematology International Journal","volume":"21 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"COVID-19-Driven Immunoparalysis and Cytokine Storm: Can Hematologists Contribute to the Battle?\",\"authors\":\"Marchetti M\",\"doi\":\"10.23880/hij-16000170\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"COVID-19 pandemia is a major health emergency causing hundreds of deaths worldwide. The high reported morbidity has been related to derangement of the immune system, cytokine overproduction and endothelial dysfunction. Several drugs currently marketed for blood disorders are being tested for potential clinical benefit in patients with COVID-19 and hematologists are valuable partners for multidisciplinary research projects assessing host-targeted therapies. This review attempts to highlight the pathogenesis of lymphopenia in COVID-19 disease and the possible treatment pathways. While discussing the pattern of cytokine hyperproduction, we also focused on anti-cytokine drugs being tested for COVID-19 disease but currently prescribed for blood disorders.\",\"PeriodicalId\":245976,\"journal\":{\"name\":\"Haematology International Journal\",\"volume\":\"21 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Haematology International Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23880/hij-16000170\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Haematology International Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23880/hij-16000170","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

COVID-19大流行是一场重大突发卫生事件,在全球造成数百人死亡。报道的高发病率与免疫系统紊乱、细胞因子过度产生和内皮功能障碍有关。目前上市的几种治疗血液疾病的药物正在测试对COVID-19患者的潜在临床益处,血液学家是评估宿主靶向治疗的多学科研究项目的宝贵合作伙伴。本文综述了COVID-19中淋巴细胞减少的发病机制和可能的治疗途径。在讨论细胞因子过度产生的模式时,我们也关注了抗细胞因子药物,这些药物正在测试用于COVID-19疾病,但目前用于血液疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COVID-19-Driven Immunoparalysis and Cytokine Storm: Can Hematologists Contribute to the Battle?
COVID-19 pandemia is a major health emergency causing hundreds of deaths worldwide. The high reported morbidity has been related to derangement of the immune system, cytokine overproduction and endothelial dysfunction. Several drugs currently marketed for blood disorders are being tested for potential clinical benefit in patients with COVID-19 and hematologists are valuable partners for multidisciplinary research projects assessing host-targeted therapies. This review attempts to highlight the pathogenesis of lymphopenia in COVID-19 disease and the possible treatment pathways. While discussing the pattern of cytokine hyperproduction, we also focused on anti-cytokine drugs being tested for COVID-19 disease but currently prescribed for blood disorders.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Sickle Cell Disease Control Prospects the Emerging Necessities Due to Impactful COVID-19 Pandemic in Sub Saharan Africa The Alfresco Aqueducts- Extrahepatic Cholangiocarcinoma Therapy with Plasma Growth Factors: Controversies of Key at Cellular Therapy Hemorrhage in the Setting of Acute Severe Refractory Immune Thrombocytopenic Purpura: A Case Report Changes in Loc285758 Expression in Response to Cytarabine- Based Treatment in Patients with Acute Myeloid Leukemia
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1